To understand why, the national ACTION survey (Understanding Patient Adherence and Concerns with Statins, and Medication Discussions with Physicians) polled more than 5,000 US adults aged 45 or older with high cholesterol who have ever used a statin.
The survey found that there’s a clear need for more conversation and education about statins, including statin intensity, risk for potential drug interactions, and dietary restrictions.
When prescribed a statin for the first time:
say they weren’t told or can’t recall being told by their healthcare provider why a particular statin was prescribed.
say they weren’t told or can’t recall being told how their prescribed statin was different from other statins.
say they weren’t told or can’t recall being told by their healthcare provider that there are different types of statins available.
say they were told that their prescribed statin could potentially interact with other medications and supplements.
On average, people who currently use a statin are taking nearly 8 other medications and/or supplements, making the risk of drug-drug interactions with statins a serious possibility for many of them;
say they aren’t concerned about their statin interacting with other medications or supplements.
Nearly 3 in 5 people (59%) say it’s extremely important to them that their healthcare provider takes an individualized approach to selecting the right statin for them.
of people currently on a high-intensity statin* (like Lipitor® [atorvastatin] or Crestor® [rosuvastatin]) say they wish they could take a lower-intensity statin to manage their high cholesterol.
say it’s extremely important that their healthcare provider considers their diet when recommending a statin.
If you’re taking a statin,
talk to your doctor to make sure the statin YOU
take is one that’s most appropriate for you.
Lipitor is a registered trademark of Pfizer, Inc.
Harris Poll conducted ACTION: The Statin Survey (Understanding Patient Adherence and Concerns with Statins, and Medication Discussions with Physicians) online on behalf of Kowa Pharmaceuticals America, Inc., within the United States from July 7- August 4, 2017, among 5,014 United States adults aged 45 or older who have been diagnosed with high cholesterol and have ever used a statin to treat high cholesterol. This online survey is not based on a probability sample, and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables, please contact Erin Bittner at W2O Group, 212-301-7226.